{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:03:12Z","timestamp":1782975792253,"version":"3.54.5"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The identification of novel non-invasive biomarkers is crucial for improving the management of chronic kidney disease (CKD) and kidney transplant recipients (KTR). While A Disintegrin and Metalloprotease 10 (ADAM10) is involved in kidney pathology, the clinical relevance of its soluble form, soluble ADAM10 (sADAM10), remains poorly defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective cohort study, we enrolled 488 participants, including 145 kidney transplant recipients (KTR), 295 patients with chronic kidney disease (CKD), and 48 healthy controls (HC). Plasma sADAM10 was measured by ELISA and evaluated for its correlation with renal function, laboratory parameters, and histopathological findings. Its prognostic value for adverse outcomes was determined using Kaplan-Meier analyses, restricted cubic spline (RCS) Cox regression, and incremental value assessment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Plasma sADAM10 were significantly elevated in biopsy-proven KTR and CKD patients compared to HC. Multivariate analyses revealed cohort-specific independent associations: plasma sADAM10 was independently associated with eGFR in CKD (standardized \u03b2 = \u20130.24, P &amp;lt; 0.001), but with neutrophil count in KTR (standardized \u03b2 = 0.24, P\u00a0=\u00a00.034). Histopathologically, higher plasma sADAM10 were associated with the severity of interstitial fibrosis and tubular atrophy (IFTA), tubular injury, and interstitial inflammation. RCS analysis demonstrated a significant non-linear association between plasma sADAM10 and post-transplant infection risk (P for non-linearity = 0.029), with plasma sADAM10 providing incremental prognostic value beyond age and eGFR (C-index increase from 0.795 to 0.842; likelihood ratio P\u00a0=\u00a00.005). In contrast, after adjusting for eGFR and proteinuria, plasma sADAM10 showed no independent association with the composite renal endpoint. For patients with advanced CKD, plasma sADAM10 concentration showed an exponential association with the predicted 5-year risk of kidney failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Plasma sADAM10 is a context-dependent biomarker with endpoint-specific prognostic value. It shows an independent association with renal dysfunction in CKD and inflammatory activation in KTR, and predicts post-transplant infection risk with incremental value beyond traditional markers. However, its apparent association with renal outcomes is confounded by eGFR. These findings highlight the potential of plasma sADAM10 for infection risk stratification in KTR and warrant further validation in larger cohorts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1752330","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:36:09Z","timestamp":1782970569000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical implications of plasma sADAM10: integrating renal function, histopathology and prognostic outcomes in chronic kidney disease and kidney transplantation"],"prefix":"10.3389","volume":"17","author":[{"given":"Xueqiao","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine\/Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University","place":["Chengdu, Sichuan, China"]},{"name":"Sichuan Clinical Research Center for Laboratory Medicine","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Pathology, General Hospital of Western Theater Command","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qu","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine\/Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University","place":["Chengdu, Sichuan, China"]},{"name":"Sichuan Clinical Research Center for Laboratory Medicine","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology, General Hospital of Western Theater Command","place":["Chengdu, Sichuan, China"]},{"name":"Tissue Stress Injury and Functional Repair Key Laboratory of Sichuan Province, General Hospital of Western Theater Command","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"An","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine\/Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University","place":["Chengdu, Sichuan, China"]},{"name":"Sichuan Clinical Research Center for Laboratory Medicine","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine\/Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University","place":["Chengdu, Sichuan, China"]},{"name":"Sichuan Clinical Research Center for Laboratory Medicine","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangjuan","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine\/Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University","place":["Chengdu, Sichuan, China"]},{"name":"Sichuan Clinical Research Center for Laboratory Medicine","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine\/Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University","place":["Chengdu, Sichuan, China"]},{"name":"Sichuan Clinical Research Center for Laboratory Medicine","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: A systematic analysis for the global burden of disease study 2017","volume":"395","year":"2020","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfac206","article-title":"Twenty years of real-world data to estimate chronic kidney disease prevalence and staging in an unselected population","volume":"16","author":"Santos-Ara\u00fajo","year":"2023","journal-title":"Clin Kidney J"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.1015902","article-title":"Regional burden of chronic kidney disease in North Africa and Middle East during 1990-2019; Results from global burden of disease study 2019","volume":"10","author":"Tabatabaei-Malazy","year":"2022","journal-title":"Front Public Health"},{"key":"B4","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"Kdigo 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","year":"2021","journal-title":"Kidney Int"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfab149","article-title":"The Indian chronic kidney disease (Ickd) study: Baseline characteristics","volume":"15","author":"Kumar","year":"2022","journal-title":"Clin Kidney J"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-024-00589-9","article-title":"Chronic kidney disease","volume":"11","author":"Romagnani","year":"2025","journal-title":"Nat Rev Dis Primers"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: The dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"Sellar\u00e9s","year":"2012","journal-title":"Am J Transplant"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/tp.0000000000000183","article-title":"The histology of kidney transplant failure: A long-term follow-up study","volume":"98","author":"Naesens","year":"2014","journal-title":"Transplantation"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-017-3712-6","article-title":"Biomarkers to detect rejection after kidney transplantation","volume":"33","author":"Dharnidharka","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116318","article-title":"Molecular markers of kidney transplantation outcome: Current omics tools and future developments","volume":"23","author":"Lepoittevin","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA120.012601","article-title":"The tetraspanin Tspan15 is an essential subunit of an Adam10 scissor complex","volume":"295","author":"Koo","year":"2020","journal-title":"J Biol Chem"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/path.5517","article-title":"Adam10 mediates ectopic proximal tubule development and renal fibrosis through Notch signalling","volume":"252","author":"Li","year":"2020","journal-title":"J Pathol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2020081213","article-title":"Adam10-mediated ectodomain shedding is an essential driver of podocyte damage","volume":"32","author":"Sachs","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2018.00153","article-title":"Renal Adam10 and 17: Their physiological and medical meanings","volume":"6","author":"Kato","year":"2018","journal-title":"Front Cell Dev Biol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/febs.16870","article-title":"New insights into the function and pathophysiology of the ectodomain sheddase a disintegrin and metalloproteinase 10 (Adam10)","volume":"291","author":"Rosenbaum","year":"2024","journal-title":"FEBS J"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-018-1956-0","article-title":"Pax2 may induce Adam10 expression in renal tubular epithelial cells and contribute to epithelial-to-mesenchymal transition","volume":"50","author":"Hou","year":"2018","journal-title":"Int Urol Nephrol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2025.04.010","article-title":"Regulation of podocyte surface proteins by the enzyme a disintegrin and metalloproteinase 10 (Adam10)","volume":"108","author":"Rosenbaum","year":"2025","journal-title":"Kidney Int"},{"key":"B18","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3892\/etm.2023.11959","article-title":"Adam metallopeptidase domain 10 knockdown enables podocytes to resist high glucose stimulation by inhibiting pyroptosis via Mapk pathway","volume":"25","author":"Sui","year":"2023","journal-title":"Exp Ther Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107480","article-title":"Ectodomain shedding of Pla2r1 is mediated by the metalloproteases Adam10 and Adam17","volume":"300","author":"Dolla","year":"2024","journal-title":"J Biol Chem"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2026.02.021","article-title":"Anti-Pla2r1 Igg-mediated podocyte Pla2r1 cleavage drives glomerular subepithelial immune complex deposition in membranous nephropathy","volume":"109","author":"Liu","year":"2026","journal-title":"Kidney Int"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2013070764","article-title":"Adam10 mediates the choice between principal cells and intercalated cells in the kidney","volume":"26","author":"Guo","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.703058","article-title":"Tspanc8 tetraspanins and a disintegrin and metalloprotease 10 (Adam10) interact via their extracellular regions: Evidence for distinct binding mechanisms for different Tspanc8 proteins","volume":"291","author":"Noy","year":"2016","journal-title":"J Biol Chem"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0068-5","article-title":"The emerging role of Adam metalloproteinases in immunity","volume":"18","author":"Lambrecht","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00499","article-title":"Targeting Adam10 in cancer and autoimmunity","volume":"11","author":"Smith","year":"2020","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201700823RR","article-title":"The metalloprotease Adam10 (a disintegrin and metalloprotease 10) undergoes rapid, postlysis autocatalytic degradation","volume":"32","author":"Brummer","year":"2018","journal-title":"FASEB J"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109710","article-title":"Decreased expression of Adam10 on monocytes is associated with chronic allograft dysfunction in kidney transplant recipients","volume":"115","author":"Li","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052416","article-title":"Adam10 plasma and Csf levels are increased in mild Alzheimer's disease","volume":"22","author":"Pereira Vatanabe","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2025.04.003","article-title":"Higher soluble Adam10 plasma levels are associated with decreased cognitive performance in older adults carrying Apoe\u03f54","volume":"151","author":"Pelegrini","year":"2025","journal-title":"Neurobiol Aging"},{"key":"B29","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12974-018-1255-9","article-title":"Levels of Adam10 are reduced in Alzheimer's disease Csf","volume":"15","author":"Sogorb-Esteve","year":"2018","journal-title":"J Neuroinflamm"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajt.2023.10.016","article-title":"The Banff 2022 kidney meeting report: Reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics","volume":"24","author":"Naesens","year":"2024","journal-title":"Am J Transplant"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.18202","article-title":"Multinational assessment of accuracy of equations for predicting risk of kidney failure: A meta-analysis","volume":"315","author":"Tangri","year":"2016","journal-title":"Jama"},{"key":"B32","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1189\/jlb.3VMAB1115-496RR","article-title":"Targeting Adam17 in leukocytes increases neutrophil recruitment and reduces bacterial spread during polymicrobial sepsis","volume":"100","author":"Mishra","year":"2016","journal-title":"J Leukoc Biol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24087309","article-title":"Adam10 and Adam17, major regulators of chronic kidney disease induced atherosclerosis","volume":"24","author":"Maas","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2021.119165","article-title":"Ectodomain shedding by Adam proteases as a central regulator in kidney physiology and disease","volume":"1869","author":"Meyer-Schwesinger","year":"2022","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/1873-3468.15078","article-title":"Calcium-sensing receptor- and Adam10-mediated Klotho shedding is regulated by tetraspanin 5","volume":"599","author":"Liu","year":"2025","journal-title":"FEBS Lett"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-019-03184-4","article-title":"Degradome of soluble Adam10 and Adam17 metalloproteases","volume":"77","author":"Scharfenberg","year":"2020","journal-title":"Cell Mol Life Sci"},{"key":"B37","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s12882-024-03736-2","article-title":"Asymmetric dimethylarginine serum concentration in normal weight and obese Ckd patients treated with hemodialysis","volume":"25","author":"Alipoor","year":"2024","journal-title":"BMC Nephrol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/alz70855_105411","article-title":"Soluble Adam10 has a decreased activity compared to membrane-bound Adam10 isoforms","volume":"21","author":"da Silva","year":"2025","journal-title":"Alzheimer's Dementia"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012309","article-title":"Asymmetric dimethylarginine is a marker of endothelial dysfunction in thrombotic antiphospholipid syndrome patients","volume":"23","author":"Stanisavljevic","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1177\/1076029620938874","article-title":"Plasma level of Von Willebrand factor propeptide at diagnosis: A marker of subsequent renal dysfunction in autoimmune rheumatic diseases","volume":"26","author":"Yada","year":"2020","journal-title":"Clin Appl Thromb Hemost"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136707","article-title":"Regulation of Adam10 by the Tspanc8 family of tetraspanins and their therapeutic potential","volume":"22","author":"Harrison","year":"2021","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1752330\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:36:10Z","timestamp":1782970570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1752330\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":41,"alternative-id":["10.3389\/fimmu.2026.1752330"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1752330","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"article-number":"1752330"}}